Compile Data Set for Download or QSAR
maximum 50k data
Found 440 with Last Name = 'imajo' and Initial = 's'
TargetChymase(Homo sapiens (Human))
Daiichi Sankyo

US Patent
LigandPNGBDBM134267(US8846660, 41)
Affinity DataIC50:  3nMpH: 7.5 T: 2°CAssay Description:The inhibitory activity of the compounds of the present invention for recombinant human chymase was measured by the method of Pasztor et al. (Pasztor...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetChymase(Homo sapiens (Human))
Daiichi Sankyo

US Patent
LigandPNGBDBM134262(US8846660, 30)
Affinity DataIC50:  4nMpH: 7.5 T: 2°CAssay Description:The inhibitory activity of the compounds of the present invention for recombinant human chymase was measured by the method of Pasztor et al. (Pasztor...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetChymase(Homo sapiens (Human))
Daiichi Sankyo

US Patent
LigandPNGBDBM134278(US8846660, 96)
Affinity DataIC50:  7nMpH: 7.5 T: 2°CAssay Description:The inhibitory activity of the compounds of the present invention for recombinant human chymase was measured by the method of Pasztor et al. (Pasztor...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetChymase(Homo sapiens (Human))
Daiichi Sankyo

US Patent
LigandPNGBDBM50452609(CHEMBL4206099)
Affinity DataIC50:  8.90nMAssay Description:Inhibition of recombinant human chymase pre-incubated for 10 mins before Suc-Ala-Ala-Pro-Phe-MCA substrate addition and measured after 10 mins by flu...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sidPDB
TargetChymase(Homo sapiens (Human))
Daiichi Sankyo

US Patent
LigandPNGBDBM134276(US8846660, 76)
Affinity DataIC50:  9nMpH: 7.5 T: 2°CAssay Description:The inhibitory activity of the compounds of the present invention for recombinant human chymase was measured by the method of Pasztor et al. (Pasztor...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetChymase(Homo sapiens (Human))
Daiichi Sankyo

US Patent
LigandPNGBDBM134263(US8846660, 31)
Affinity DataIC50:  10nMpH: 7.5 T: 2°CAssay Description:The inhibitory activity of the compounds of the present invention for recombinant human chymase was measured by the method of Pasztor et al. (Pasztor...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetChymase(Homo sapiens (Human))
Daiichi Sankyo

US Patent
LigandPNGBDBM134261(US8846660, 29)
Affinity DataIC50:  10nMpH: 7.5 T: 2°CAssay Description:The inhibitory activity of the compounds of the present invention for recombinant human chymase was measured by the method of Pasztor et al. (Pasztor...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetChymase(Homo sapiens (Human))
Daiichi Sankyo

US Patent
LigandPNGBDBM134266(US8846660, 40)
Affinity DataIC50:  10nMpH: 7.5 T: 2°CAssay Description:The inhibitory activity of the compounds of the present invention for recombinant human chymase was measured by the method of Pasztor et al. (Pasztor...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetChymase(Homo sapiens (Human))
Daiichi Sankyo

US Patent
LigandPNGBDBM50210107(7-chloro-3-(4-chlorophenylsulfonyl)quinazoline-2,4...)
Affinity DataIC50:  18nMAssay Description:Inhibition of human recombinant chymaseMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetChymase(Homo sapiens (Human))
Daiichi Sankyo

US Patent
LigandPNGBDBM50058973(3-(3,4-Dichloro-benzenesulfonyl)-1-phenyl-imidazol...)
Affinity DataIC50:  18nMAssay Description:Inhibitory activity against human heart chymase in vitro.More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetChymase(Homo sapiens (Human))
Daiichi Sankyo

US Patent
LigandPNGBDBM100749(US8507714, 214)
Affinity DataIC50:  19nMAssay Description:Inhibitory activity of the compounds for recombinant human chymase was measured by method of Pasztor et al. (Pasztor et al., Acta Biol. Hung. 42:285-...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetChymase(Homo sapiens (Human))
Daiichi Sankyo

US Patent
LigandPNGBDBM100743(US8507714, 67)
Affinity DataIC50:  19nMAssay Description:Inhibitory activity of the compounds for recombinant human chymase was measured by method of Pasztor et al. (Pasztor et al., Acta Biol. Hung. 42:285-...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetChymase(Homo sapiens (Human))
Daiichi Sankyo

US Patent
LigandPNGBDBM134253(US8846660, 103 | US8846660, 12)
Affinity DataIC50:  20nMpH: 7.5 T: 2°CAssay Description:The inhibitory activity of the compounds of the present invention for recombinant human chymase was measured by the method of Pasztor et al. (Pasztor...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetChymase(Homo sapiens (Human))
Daiichi Sankyo

US Patent
LigandPNGBDBM134256(US8846660, 18)
Affinity DataIC50:  20nMpH: 7.5 T: 2°CAssay Description:The inhibitory activity of the compounds of the present invention for recombinant human chymase was measured by the method of Pasztor et al. (Pasztor...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetChymase(Homo sapiens (Human))
Daiichi Sankyo

US Patent
LigandPNGBDBM50058984(3-(3,4-Dichloro-benzenesulfonyl)-1-(3,4-dimethyl-p...)
Affinity DataIC50:  20nMAssay Description:Inhibitory activity against human heart chymase in vitro.More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetChymase(Homo sapiens (Human))
Daiichi Sankyo

US Patent
LigandPNGBDBM134272(US8846660, 58)
Affinity DataIC50:  20nMpH: 7.5 T: 2°CAssay Description:The inhibitory activity of the compounds of the present invention for recombinant human chymase was measured by the method of Pasztor et al. (Pasztor...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetChymase(Homo sapiens (Human))
Daiichi Sankyo

US Patent
LigandPNGBDBM134260(US8846660, 27)
Affinity DataIC50:  20nMpH: 7.5 T: 2°CAssay Description:The inhibitory activity of the compounds of the present invention for recombinant human chymase was measured by the method of Pasztor et al. (Pasztor...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetChymase(Homo sapiens (Human))
Daiichi Sankyo

US Patent
LigandPNGBDBM134269(US8846660, 44)
Affinity DataIC50:  20nMpH: 7.5 T: 2°CAssay Description:The inhibitory activity of the compounds of the present invention for recombinant human chymase was measured by the method of Pasztor et al. (Pasztor...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetChymase(Homo sapiens (Human))
Daiichi Sankyo

US Patent
LigandPNGBDBM134268(US8846660, 42)
Affinity DataIC50:  20nMpH: 7.5 T: 2°CAssay Description:The inhibitory activity of the compounds of the present invention for recombinant human chymase was measured by the method of Pasztor et al. (Pasztor...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetChymase(Homo sapiens (Human))
Daiichi Sankyo

US Patent
LigandPNGBDBM50058990(3-(3,4-Dimethoxy-benzenesulfonyl)-1-(3,4-dimethyl-...)
Affinity DataIC50:  22nMAssay Description:Inhibitory activity against human heart chymase in vitro.More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetChymase(Homo sapiens (Human))
Daiichi Sankyo

US Patent
LigandPNGBDBM50210098(6-(4,5-dichloro-2-methoxybenzyl)-4-(4-chlorophenyl...)
Affinity DataIC50:  23nMAssay Description:Inhibition of human recombinant chymaseMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetChymase(Homo sapiens (Human))
Daiichi Sankyo

US Patent
LigandPNGBDBM50058996(3-(4-Chloro-benzenesulfonyl)-1-(3,4-dichloro-pheny...)
Affinity DataIC50:  23nMAssay Description:Inhibitory activity against human heart chymase in vitro.More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetChymase(Homo sapiens (Human))
Daiichi Sankyo

US Patent
LigandPNGBDBM100752(US8507714, 269)
Affinity DataIC50:  24nMAssay Description:Inhibitory activity of the compounds for recombinant human chymase was measured by method of Pasztor et al. (Pasztor et al., Acta Biol. Hung. 42:285-...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetChymase(Homo sapiens (Human))
Daiichi Sankyo

US Patent
LigandPNGBDBM50210116(6-(5-fluoro-2-methoxybenzyl)-4-(4-chlorophenylsulf...)
Affinity DataIC50:  26nMAssay Description:Inhibition of human recombinant chymaseMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetChymase(Homo sapiens (Human))
Daiichi Sankyo

US Patent
LigandPNGBDBM50210120((S)-6-(5-chloro-2-methoxybenzyl)-4-(4-chlorophenyl...)
Affinity DataIC50:  27nMAssay Description:Inhibition of human recombinant chymaseMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetChymase(Homo sapiens (Human))
Daiichi Sankyo

US Patent
LigandPNGBDBM50210094(3-((1-(4-chlorophenylsulfonyl)-3,7-dioxo-1,4-diaze...)
Affinity DataIC50:  27nMAssay Description:Inhibition of human recombinant chymaseMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetChymase(Homo sapiens (Human))
Daiichi Sankyo

US Patent
LigandPNGBDBM50059007(4-(2,5-Dioxo-3-phenyl-imidazolidine-1-sulfonyl)-be...)
Affinity DataIC50:  29nMAssay Description:Inhibitory activity against human heart chymase in vitro.More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetChymase(Homo sapiens (Human))
Daiichi Sankyo

US Patent
LigandPNGBDBM134252(US8846660, 3)
Affinity DataIC50:  30nMpH: 7.5 T: 2°CAssay Description:The inhibitory activity of the compounds of the present invention for recombinant human chymase was measured by the method of Pasztor et al. (Pasztor...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetChymase(Homo sapiens (Human))
Daiichi Sankyo

US Patent
LigandPNGBDBM134275(US8846660, 73)
Affinity DataIC50:  30nMpH: 7.5 T: 2°CAssay Description:The inhibitory activity of the compounds of the present invention for recombinant human chymase was measured by the method of Pasztor et al. (Pasztor...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetChymase(Homo sapiens (Human))
Daiichi Sankyo

US Patent
LigandPNGBDBM134264(US8846660, 34)
Affinity DataIC50:  30nMpH: 7.5 T: 2°CAssay Description:The inhibitory activity of the compounds of the present invention for recombinant human chymase was measured by the method of Pasztor et al. (Pasztor...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetChymase(Homo sapiens (Human))
Daiichi Sankyo

US Patent
LigandPNGBDBM134273(US8846660, 64)
Affinity DataIC50:  30nMpH: 7.5 T: 2°CAssay Description:The inhibitory activity of the compounds of the present invention for recombinant human chymase was measured by the method of Pasztor et al. (Pasztor...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetChymase(Homo sapiens (Human))
Daiichi Sankyo

US Patent
LigandPNGBDBM134270(US8846660, 49)
Affinity DataIC50:  30nMpH: 7.5 T: 2°CAssay Description:The inhibitory activity of the compounds of the present invention for recombinant human chymase was measured by the method of Pasztor et al. (Pasztor...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetChymase(Homo sapiens (Human))
Daiichi Sankyo

US Patent
LigandPNGBDBM50058964(3-(3,4-Dimethyl-benzenesulfonyl)-1-phenyl-imidazol...)
Affinity DataIC50:  30nMAssay Description:Inhibitory activity against human heart chymase in vitro.More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetChymase(Homo sapiens (Human))
Daiichi Sankyo

US Patent
LigandPNGBDBM134254(US8846660, 14)
Affinity DataIC50:  30nMpH: 7.5 T: 2°CAssay Description:The inhibitory activity of the compounds of the present invention for recombinant human chymase was measured by the method of Pasztor et al. (Pasztor...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetChymase(Homo sapiens (Human))
Daiichi Sankyo

US Patent
LigandPNGBDBM134255(US8846660, 15)
Affinity DataIC50:  30nMpH: 7.5 T: 2°CAssay Description:The inhibitory activity of the compounds of the present invention for recombinant human chymase was measured by the method of Pasztor et al. (Pasztor...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetChymase(Homo sapiens (Human))
Daiichi Sankyo

US Patent
LigandPNGBDBM134257(US8846660, 20)
Affinity DataIC50:  30nMpH: 7.5 T: 2°CAssay Description:The inhibitory activity of the compounds of the present invention for recombinant human chymase was measured by the method of Pasztor et al. (Pasztor...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetChymase(Homo sapiens (Human))
Daiichi Sankyo

US Patent
LigandPNGBDBM134280(US8846660, 108)
Affinity DataIC50:  30nMpH: 7.5 T: 2°CAssay Description:The inhibitory activity of the compounds of the present invention for recombinant human chymase was measured by the method of Pasztor et al. (Pasztor...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetChymase(Homo sapiens (Human))
Daiichi Sankyo

US Patent
LigandPNGBDBM50210743(6-(4-chloro-2-methoxybenzyl)-4-(4-chlorophenylsulf...)
Affinity DataIC50:  34nMAssay Description:Inhibition of human recombinant chymaseMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetChymase(Homo sapiens (Human))
Daiichi Sankyo

US Patent
LigandPNGBDBM100740(CHEMBL391608 | US8507714, 29)
Affinity DataIC50:  34nMAssay Description:Inhibition of human recombinant chymaseMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetChymase(Homo sapiens (Human))
Daiichi Sankyo

US Patent
LigandPNGBDBM100740(CHEMBL391608 | US8507714, 29)
Affinity DataIC50:  34nMAssay Description:Inhibitory activity of the compounds for recombinant human chymase was measured by method of Pasztor et al. (Pasztor et al., Acta Biol. Hung. 42:285-...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetChymase(Homo sapiens (Human))
Daiichi Sankyo

US Patent
LigandPNGBDBM50058969(3-(4-Chloro-benzenesulfonyl)-1-(3,4-dimethyl-pheny...)
Affinity DataIC50:  35nMAssay Description:Inhibitory activity against human heart chymase in vitro.More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetChymase(Homo sapiens (Human))
Daiichi Sankyo

US Patent
LigandPNGBDBM50210099(CHEMBL246964 | rac-2q)
Affinity DataIC50:  39nMAssay Description:Inhibition of human recombinant chymaseMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetChymase(Homo sapiens (Human))
Daiichi Sankyo

US Patent
LigandPNGBDBM50058972(4-(2,5-Dioxo-3-phenyl-imidazolidine-1-sulfonyl)-be...)
Affinity DataIC50:  40nMAssay Description:Inhibitory activity against human heart chymase in vitro.More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetChymase(Homo sapiens (Human))
Daiichi Sankyo

US Patent
LigandPNGBDBM134271(US8846660, 53)
Affinity DataIC50:  40nMpH: 7.5 T: 2°CAssay Description:The inhibitory activity of the compounds of the present invention for recombinant human chymase was measured by the method of Pasztor et al. (Pasztor...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetChymase(Homo sapiens (Human))
Daiichi Sankyo

US Patent
LigandPNGBDBM134258(US8846660, 22)
Affinity DataIC50:  40nMpH: 7.5 T: 2°CAssay Description:The inhibitory activity of the compounds of the present invention for recombinant human chymase was measured by the method of Pasztor et al. (Pasztor...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetChymase(Homo sapiens (Human))
Daiichi Sankyo

US Patent
LigandPNGBDBM134281(US8846660, 113)
Affinity DataIC50:  40nMpH: 7.5 T: 2°CAssay Description:The inhibitory activity of the compounds of the present invention for recombinant human chymase was measured by the method of Pasztor et al. (Pasztor...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetChymase(Homo sapiens (Human))
Daiichi Sankyo

US Patent
LigandPNGBDBM50210096(2-(4-chloro-2-((1-(4-chlorophenylsulfonyl)-3,7-dio...)
Affinity DataIC50:  42nMAssay Description:Inhibition of human recombinant chymaseMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetChymase(Homo sapiens (Human))
Daiichi Sankyo

US Patent
LigandPNGBDBM87059(CHEMBL247767 | Chymostatin)
Affinity DataIC50:  43nMAssay Description:Inhibition of human recombinant chymaseMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetKallikrein-7(Homo sapiens (Human))
Asubio Pharma

Curated by ChEMBL
LigandPNGBDBM50460879(CHEMBL4228441)
Affinity DataIC50:  48nMAssay Description:Inhibition of recombinant human KLK7 using MOCAc-Arg-Pro-Lys-Pro-Val-Glu-Nva-Trp-Arg-Lys(Dnp)-NH2 as substrate preincubated for 10 mins followed by s...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails ArticlePubMed
TargetChymotrypsinogen A(Bos taurus (bovine))
Suntory

Curated by ChEMBL
LigandPNGBDBM50058977(3-Benzoyl-1-phenyl-imidazolidine-2,4-dione | CHEMB...)
Affinity DataIC50:  48nMAssay Description:Inhibitory activity against bovine pancreas alpha-chymotrypsin in vitroMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
Displayed 1 to 50 (of 440 total ) | Next | Last >>
Jump to: